11.04.2017
- Recipharm has appointed Henrik Stenqvist as the company's new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. He will be based at the...
26.08.2016
- Sweden-based drug developer and toll manufacturer Recipharm is investing €3.7 million in expanding its lyophilization capacity at Masate, Italy, near Milan. The company said the...
20.04.2016
- Sweden’s Recipharm has boosted its position in global contract development and manufacturing operations (CDMO) with agreements to buy Kemwell’s businesses in Sweden, the US and...
26.02.2016
- Swedish drug developer and toll manufacturer Recipharm has acquired Italian contract company Mitim for €68 million. The acquisition of the family-owned firm, which is located in...
29.12.2015
- Swedish drug developer and toll manufacturer Recipharm has signed a long-term agreement with Swiss eye-care treatment company Alcon, part of Novartis, to manufacture a range of...
18.11.2015
- Sweden’s Recipharm has agreed to extend a manufacturing and supply agreement for Erdosteine API with Korean drugs firm Daewoong Pharmaceutical. The existing contract has been...
21.10.2015
- Swedish drug developer and toll manufacturer Recipharm plans to acquire a majority stake in Nitin Lifesciences, an Indian sterile injectables toll manufacturer founded and...
30.06.2015
- Amine Tahiri has joined the Development Services Sales team of Recipharm as sales director for France with effect from July 1, 2015. Tahiri has more than 16 years of experience in...